|
|
Volumn 29, Issue 12, 2002, Pages 963-965
|
|
Lorazepam for seizure prohylaxis during high-dose busulfan admistration
a
|
|
Author keywords
Hematopoietic stem cell transplantation; High dose busulfan; Lorazepam; Pediatrics; Phenytoin; Seizure
|
|
Indexed keywords
ANTIEMETIC AGENT;
BUSULFAN;
CYCLOPHOSPHAMIDE;
DIPHENHYDRAMINE;
LORAZEPAM;
METHOTREXATE;
ONDANSETRON;
PHENYTOIN;
PROMETHAZINE;
TACROLIMUS;
THIOTEPA;
ALKYLATING AGENT;
ANTICONVULSIVE AGENT;
ANTINEOPLASTIC AGENT;
ADOLESCENT;
AREA UNDER THE CURVE;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DROWSINESS;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG MEGADOSE;
DRUG TOLERABILITY;
FEMALE;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
HUNTER SYNDROME;
INFANT;
LEUKEMIA;
LYMPHOMA;
MALE;
NAUSEA AND VOMITING;
PRIORITY JOURNAL;
PROPHYLAXIS;
SEIZURE;
SKIN ALLERGY;
ADULT;
BLOOD DISEASE;
CHEMICALLY INDUCED DISORDER;
DRUG INTERACTION;
IMMUNOSUPPRESSIVE TREATMENT;
METABOLIC CLEARANCE RATE;
METHODOLOGY;
PRESCHOOL CHILD;
SLEEP STAGE;
ADOLESCENT;
ADULT;
ANTICONVULSANTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BUSULFAN;
CHILD;
CHILD, PRESCHOOL;
DRUG INTERACTIONS;
FEMALE;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
INFANT;
LORAZEPAM;
MALE;
METABOLIC CLEARANCE RATE;
SEIZURES;
SLEEP STAGES;
TRANSPLANTATION CONDITIONING;
|
|
EID: 0036321897
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1703593 Document Type: Article |
|
Times cited : (45)
|
|
References (18)
|
